Clinical Trial Update: Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma [Phase 2]

View source ↗

Summary

Phase 2 study of TBL 12 sea cucumber extract in patients with untreated asymptomatic myeloma; the trial was terminated and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Smoldering Multiple Myeloma

Drugs mentioned

• TBL 12 Sea Cucumber Extract

Snippet

Sponsor: Jagannath, Sundar, M.D. | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2016-07-22